Vicarious Surgical (RBOT) Net Income towards Common Stockholders (2020 - 2025)

Vicarious Surgical (RBOT) reported Net Income towards Common Stockholders of -$11.1 million for Q3 2025, up 35.3% year-over-year from -$8.2 million in Q3 2024, and up 16.32% quarter-over-quarter from -$13.2 million in Q2 2025.

Vicarious Surgical (RBOT) Net Income towards Common Stockholders (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$11.1 million in Q3 2025.

  • Net Income towards Common Stockholders for Q3 2025 came in at -$11.1 million, up 35.3% year-over-year; the trailing twelve-month figure through Dec 2025 was -$39.7 million (up 37.26% YoY), and the FY2024 annual result was -$63.2 million, up 11.04% from the prior year.
  • Net Income towards Common Stockholders advanced to -$11.1 million in Q3 2025 per RBOT's latest filing, from -$13.2 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $42.5 million in Q1 2022 and troughed at -$45.1 million in Q3 2021.
  • A 5-year average of -$10.7 million and a median of -$13.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2021 and 2022: Net Income towards Common Stockholders plunged 24757.7% in 2021, then jumped 912.98% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $21.8 million in 2021, then sank by 151.32% to -$11.2 million in 2022, then decreased by 17.27% to -$13.1 million in 2023, then slipped by 6.22% to -$13.9 million in 2024, then increased by 20.59% to -$11.1 million in 2025.
  • Business Quant data shows RBOT's Net Income towards Common Stockholders at -$11.1 million in Q3 2025, -$13.2 million in Q2 2025, and -$15.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Vicarious Surgical - - - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -11.06 Mn
Jun 30, 2025 -13.22 Mn
Mar 31, 2025 -15.39 Mn
Dec 31, 2024 -13.93 Mn
Sep 30, 2024 -17.09 Mn
Jun 30, 2024 -15.21 Mn
Mar 31, 2024 -17.00 Mn
Dec 31, 2023 -13.11 Mn
Sep 30, 2023 -15.70 Mn
Jun 30, 2023 -15.33 Mn
Mar 31, 2023 -26.92 Mn
Dec 31, 2022 -11.18 Mn
Sep 30, 2022 -24.74 Mn
Jun 30, 2022 -1.45 Mn
Mar 31, 2022 42.53 Mn
Dec 31, 2021 21.79 Mn
Sep 30, 2021 -45.12 Mn
Jun 30, 2021 -6.64 Mn
Mar 31, 2021 -5.23 Mn
Dec 31, 2020 -3.78 Mn